Product Quantum (Rs. Cr) Long Term Rating Short Term Rating
Bank Loan Ratings 73.00 - ACUITE A3 | Reaffirmed
Total Outstanding 73.00 - -
Total Withdrawn 0.00 - -
 
Rating Rationale

Acuité has reaffirmed the short-term rating of ‘ACUITE A3’ (read as ACUITE A three) to the Rs. 73.00 crore bank facilities of Jyotindra International (JI).

Rationale for reaffirmation
The rating reaffirmation takes into account the growing operating performance of the group over the past two years. The rating also factors in the established track record of operations of the group supported by experienced management. However, the rating remains constrained on account of average financial risk profile and working capital intensive operations of the group. Further, the operating performance is susceptible to seed availability and volatility in the raw material prices.?

 


About the Company

Established in 1973, Jyotindra International (JI) is a Gujarat-based partnership firm promoted by late Mr. Jyotindra Modh and family. The firm is engaged in processing of psyllium husk and psyllium husk powder from psyllium seeds (Isabgul seeds). The firm has its own manufacturing facility located at Palanpur, Gujarat with an installed processing capacity of 7,500 MTPA. The firm exports around 70 percent of its produce to the countries like UK, Europe, Spain, Brazil, USA, China, etc. and sells around 30 percent in domestic market. Currently, the operations of JI is managed by Mr. Dhaval R Modh, Mr. Rajendra N.Modh, Mrs. Alkaben R. Modh and Mrs. Urmilaben J. Modh.

 
About the Group

­Ispasen Remedies Private Limited (IRPL)
Gujarat based Ispasen Remedies is a sister concern of JI. The firm was incorporated in 2014 and is engaged in processing of psyllium husk and psyllium husk powder from psyllium seeds (Isabgul seeds). In August 2022, the firm was converted into a private limited company. IRPL caters to local market in Gujarat and has installed capacity of 3,000 MTPA.  Mrs. Urmilaben J. Modh and Mrs. Ruchi Dhaval Modh are the current directors of the firm.

Jyotindra Industries Private Limited (JIPL)
Jyotindra Industries Private Limited (JIPL) is also a sister concern of JI. It was incorporated in 2020 in Gujarat, however, the operations commenced from FY2023 onwards. JIPL is engaged in processing of psyllium husk and psyllium husk powder from psyllium seeds (Isabgul seeds) and has a manufacturing capacity of 10,000 MTPA. It exports majority of its produce to countries like Brazil, Germany, Thailand, Malaysia, Indonesia, etc. Mr. Dhaval R Modh and Mrs. Ruchi Dhaval Modh are the directors of the company.

 

 
Unsupported Rating
­Not Applicable
 
Analytical Approach

Extent of Consolidation
•Full Consolidation
Rationale for Consolidation or Parent / Group / Govt. Support

Acuite has considered the consolidated business and financial risk profiles of Jyotindra International (JI), Ispasen Remedies Private Limited (IRPL) and Jyotindra Industries Private Limited (JIPL). The consolidation is on account of common management, similar line of business, operational and financial linkages. Further, Jyotindra International has provided corporate guarantee towards Jyotindra Industries Private Limited.

Key Rating Drivers

Strengths

­Established track record of operations and experienced management
JI has an operational track record of over five decades in manufacturing and processing of psyllium husk and powder. The group was established in 1972 by Late Mr. Jyotindra Modh and is currently managed by the second generation of the Modh family. The extensive experience of the management has helped the group in establishing long standing relations with its customers and suppliers thereby securing stable orderflow from clients.
Acuité believes that JI will continue to benefit from its experienced management and established track record of operations.

Growing operating performance
The revenue of the group improved to Rs. 334.96 Cr. in FY2024 from Rs. 284.34 Cr. in FY2023, with y-o-y growth of ~18 percent. In FY2024, the prices of psyllium seeds had increased significantly as there was shortage of the same due to unseasonal rains in some areas under cultivation. Therefore, while the volumes were affected due to low availability, the high realisations led to growth in the FY2024 revenue. The prices stabilised in FY2025 with ample availability; therefore, group recorded a revenue of Rs 366.51 Cr. till 11M FY2025. Further, the EBITDA margins improved to 4.09 percent in FY2024 from 2.65 percent in FY2023 due to decline in the overall selling costs of the group. Moreover, the EBITDA margin is expected to remain rangebound at around 4-5% owing to pass through of raw material volatility. The PAT margin however stood declined at 1.52 percent in FY2024 as against 1.96 percent in FY2023 due to increase in the finance cost of the group.
Going forward, growth in the scale of operations while maintaining profitability margins will be a key rating sensitivity.

 


Weaknesses

­Average financial risk profile
The financial risk profile of the group is average, with moderate networth, moderate gearing and average debt protection indictors. While the net worth improved to Rs. 26.11 Cr. on March 31, 2024 as against Rs. 23.35 Cr. on March 31, 2023, the substantial increase in the working capital debt levels of the group led to deterioration in the gearing to 2.81 times on March 31, 2024 from 2.14 times on March 31, 2023. The increased debt levels have also affected the Debt-EBITDA levels, which stood high at 5.18 times on March 31, 2024 as against 4.72 times on March 31, 2023. The debt protection indicators also moderated with interest coverage ratio (ICR) at 2.24 times in FY2024 as against 3.03 times in FY2023 and debt service coverage ratio (DSCR) at 1.92 times in FY2024 as against 2.85 times in FY2023. Further, in FY25 JIPL has availed debt of Rs 2.9 Cr. towards development of solar plant and equipment purchase.

The financial risk profile of the group is expected to remain on similar levels in the medium term on account of working capital limit utilization.

Intensive working capital operations
The operations of the group are working capital intensive with Gross Current Assets (GCA) of 93 days on March 31, 2024 as against 69 days on March 31, 2023 due to increase in the inventory days which stood at 59 days on March 31, 2024 as against 39 days on March 31, 2023. This increase in the inventory was on account of decline in the sales volume of JI, which led to inventory pile up. There was also an increase in the debtor days, which stood at 30 days on March 31, 2024 as against 24 days on March 31, 2023. The group’s majority procurement of raw materials and processing of the same is done during the peak period i.e April – July, therefore, the bank limit utilization during the same is on a higher side between 80 – 90 percent. Further, The bank limit utilization stood at 70.78 percent for the last six months ended February 2025. Going forward, restriction of further elongation in the working capital cycle will be a key rating sensitivity.

Susceptibility of operating performance to seed availability and volatility in the raw material prices
Psyllium seeds is the major raw material for the group. It being an agricultural produce, the availability and pricing of the same depends upon various factors such as monsoon during the year, area under cultivation, demand domestically and internationally along with various other factors. Any change in the monsoon/climate conditions may interrupt the supply of psyllium and also affect the prices of the seeds.

 

Rating Sensitivities
  • Continued growth in scale of operations while maintaining profitability margins.
  • Restriction of further elongation in the working capital cycle.
  • Significant deterioration in the financial risk profile.­
 
Liquidity Position
Adequate

­The liquidity position of the group is adequate with generation of net cash accruals (NCAs) of Rs. 7.00 Cr. as against maturing repayment obligations of Rs. 0.65 Cr. in FY2024. The NCAs are expected to remain in the range of Rs. 8 -10 Cr. with maturing repayments in the range of Rs. 1 – 1.5 Cr. in FY2025 and FY2026. The current ratio stood average at 1.31 times on March 31, 2024. The group had an unencumbered cash and bank balance of Rs. 0.15 Cr. on March 31, 2024. The average bank limit utilization stood at 70.78 percent for the last six months ended February 2025.

 
Outlook: Not Applicable
­
 
Other Factors affecting Rating
­None
 

Particulars Unit FY 24 (Actual) FY 23 (Actual)
Operating Income Rs. Cr. 334.96 284.34
PAT Rs. Cr. 5.09 5.58
PAT Margin (%) 1.52 1.96
Total Debt/Tangible Net Worth Times 2.81 2.14
PBDIT/Interest Times 2.24 3.03
Status of non-cooperation with previous CRA (if applicable)
­Not Applicable
 
Interaction with Audit Committee anytime in the last 12 months (applicable for rated-listed / proposed to be listed debt securities being reviewed by Acuite)
Not applicable
Any Other Information
­None
 
Applicable Criteria
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm
• Consolidation Of Companies: https://www.acuite.in/view-rating-criteria-60.htm
• Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm

Note on complexity levels of the rated instrument

Date Name of Instruments/Facilities Term Amount (Rs. Cr) Rating/Outlook
08 Jan 2024 PC/PCFC Short Term 25.00 ACUITE A3 (Reaffirmed)
PC/PCFC Short Term 40.00 ACUITE A3 (Reaffirmed)
Proposed Short Term Bank Facility Short Term 1.00 ACUITE A3 (Reaffirmed)
Stand By Line of Credit Short Term 7.00 ACUITE A3 (Reaffirmed)
10 Oct 2022 PC/PCFC Short Term 30.00 ACUITE A3 (Reaffirmed)
PC/PCFC Short Term 10.00 ACUITE A3 (Assigned)
PC/PCFC Short Term 25.00 ACUITE A3 (Reaffirmed)
Stand By Line of Credit Short Term 5.00 ACUITE A3 (Reaffirmed)
Stand By Line of Credit Short Term 2.00 ACUITE A3 (Assigned)
Proposed Short Term Bank Facility Short Term 1.00 ACUITE A3 (Assigned)
­

Lender’s Name ISIN Facilities Date Of Issuance Coupon Rate Maturity Date Quantum
(Rs. Cr.)
Complexity Level Rating
Yes Bank Ltd Not avl. / Not appl. PC/PCFC Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 25.00 Simple ACUITE A3 | Reaffirmed
Bank of Baroda Not avl. / Not appl. PC/PCFC Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 40.00 Simple ACUITE A3 | Reaffirmed
Not Applicable Not avl. / Not appl. Proposed Short Term Bank Facility Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 1.00 Simple ACUITE A3 | Reaffirmed
Bank of Baroda Not avl. / Not appl. Stand By Line of Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 7.00 Simple ACUITE A3 | Reaffirmed
*Annexure 2 - List of Entities (applicable for Consolidation or Parent / Group / Govt. Support)
­
Sr. No   Company Name
1   Jyotindra International
2   Ispasen Remedies Private Limited 
3   Jyotindra Industries Private Limited 
 

Contacts

About Acuité Ratings & Research

© Acuité Ratings & Research Limited. All Rights Reserved.www.acuite.in